Somatic Mosaicism as Modulator of the Global and Intellectual Phenotype in Epimutated Angelman Syndrome Patients
DOI:
https://doi.org/10.6000/2292-2598.2015.03.03.2Keywords:
Mosaicism, intellectual disability, Angelman syndrome, epimutation, uniparental disomyAbstract
Angelman Syndrome (AS) is due to the loss of function of the single UBE3A gene, mapping to chromosome 15q11-q13 and encoding the E6AP ubiquitin ligase. Expression of UBE3A is subject to genomic imprinting which is restricted to the brain, where only the maternal allele is transcribed. AS pathogenetic mechanisms include deletion of the maternal 15q11-13 chromosomal region, chromosome 15 paternal uniparental disomy (UPD), Imprinting Defects (ImpD) leading to silencing of the maternal allele and intragenic mutations of the maternal UBE3A allele. From our AS cohort we sorted out for detailed clinical-molecular characterization six mosaic cases, five with ImpD epimutations and one with patUPD15. This latter case referred for intellectual disability and fortuitously solved by SNP array, is, to our knowledge, the unique patient reported with mosaic patUPD of this imprinted region. Somatic epimutation mosaicism represents a challenge for both clinical and molecular diagnostics. The described patients, referred to our center either for uncertain AS or simply for intellectual disability, could be molecularly characterized by applying a multi-method approach including Methylation-Sensitive PCR and MS-MLPA without a strict cut off. The percentage of normal cells detected ranged up to 40%. We confirm the mild phenotype reported in mosaic AS ImpD and provide a detailed analysis of IQ. Mild mental retardation, with significant difficulties in language expression, but only mildly impaired performance skills, together with pathognomonic EEG, is a cue not to overlook in mosaic AS patients. Mosaic epimutations should be searched also in patients with minor AS features and presenting only with intellectual disability.
References
Karam SM, Riegel M, Segal SL, et al. Genetic causes of intellectual disability in a birth cohort: A population-based study. Am J Med Genet A 2015; 167(6): 1204-1214. http://dx.doi.org/10.1002/ajmg.a.37011 DOI: https://doi.org/10.1002/ajmg.a.37011
Kaufman L, Ayub M, Vincent JB. The genetic basis of non-syndromic intellectual disability: a review. J Neurodevelop Disord 2010; 2: 182-209. http://dx.doi.org/10.1007/s11689-010-9055-2 DOI: https://doi.org/10.1007/s11689-010-9055-2
Ropers HH. X-linked mental retardation: many genes for a complex disorder. Curr Opin Genet Dev 2006; 16(3): 260-269. http://dx.doi.org/10.1016/j.gde.2006.04.017 DOI: https://doi.org/10.1016/j.gde.2006.04.017
Williams CA, Angelman H, Clayton-Smith J, et al. Angelman syndrome: consensus for diagnostic criteria. Angelman Syndrome Foundation. Am J Med Genet 1995; 56(2): 237-238. http://dx.doi.org/10.1002/ajmg.1320560224 DOI: https://doi.org/10.1002/ajmg.1320560224
Williams CA, Beaudet al, Clayton-Smith J, et al. Angelman Syndrome 2005: updated consensus for diagnostic criteria. Am J Med Genet A 2006; 140(5): 413-418. http://dx.doi.org/10.1002/ajmg.a.31074 DOI: https://doi.org/10.1002/ajmg.a.31074
Kishino T, Lalande M, Wagstaff J. UBE3A/E6-AP mutations cause Angelman syndrome. Nat Genet 1997; 15(1): 70-73. http://dx.doi.org/10.1038/ng0197-70 DOI: https://doi.org/10.1038/ng0197-70
Dagli A, Buiting K, Williams CA. Molecular and clinical aspects of Angelman syndrome. Mol Syndromol 2012; 2(3-5): 100-112. DOI: https://doi.org/10.1159/000328837
Buiting K, Clayton-Smith J, Driscoll DJ, et al. Clinical utility gene card for: Angelman Syndrome. Eur J Hum Genet 2014; 23(2). http://dx.doi.org/10.1038/ejhg.2014.93 DOI: https://doi.org/10.1038/ejhg.2014.93
Dindot SV, Antalffy BA, Bhattacharjee MB, Beaudet al. The Angelman syndrome ubiquitin ligase localizes to the synapse and nucleus, and maternal deficiency results in abnormal dendritic spine morphology. Hum Mol Genet 2008; 17(1): 111-118. http://dx.doi.org/10.1093/hmg/ddm288 DOI: https://doi.org/10.1093/hmg/ddm288
Yashiro K, Riday TT, Condon KH, et al. Ube3a is required for experience-dependent maturation of the neocortex. Nat Neurosci 2009; 12(6): 777-783. http://dx.doi.org/10.1038/nn.2327 DOI: https://doi.org/10.1038/nn.2327
Mabb AM, Judson MC, Zylka MJ, Philpot BD. Angelman syndrome: insights into genomic imprinting and neurodevelopmental phenotypes. Trends Neurosci 2011; 34(6): 293-303. http://dx.doi.org/10.1016/j.tins.2011.04.001 DOI: https://doi.org/10.1016/j.tins.2011.04.001
Lossie AC, Whitney MM, Amidon D, et al. Phenotypes distinguish the molecular classes of Angelman syndrome. J Med Genet 2001; 38(12): 834-845. http://dx.doi.org/10.1136/jmg.38.12.834 DOI: https://doi.org/10.1136/jmg.38.12.834
Gentile JK, Tan WH, Horowitz LT, et al. A Neurodevelopmental survey of Angelman syndrome with genotype-phenotype correlations. J Dev Behav Pediatr 2010; 31(7): 592-601. http://dx.doi.org/10.1097/dbp.0b013e3181ee408e DOI: https://doi.org/10.1097/DBP.0b013e3181ee408e
Tan WH, Bacino CA, Skinner SA, et al. Angelman syndrome: Mutations influence features in early childhood. Am J Med Genet A 2010; 155A(1): 81-90. DOI: https://doi.org/10.1002/ajmg.a.33775
Gillessen-Kaesbach G, Demuth S, Thiele H, et al. A previously unrecognised phenotype characterised by obesity, muscular hypotonia, and ability to speak in patients with Angelman syndrome caused by an imprinting defect. Eur J Hum Genet 1999; 7(6): 638-644. http://dx.doi.org/10.1038/sj.ejhg.5200362 DOI: https://doi.org/10.1038/sj.ejhg.5200362
Nazlican H, Zeschnigk M, Claussen U, et al. Somatic mosaicism in patients with Angelman syndrome and an imprinting defect. Hum Mol Genet 2004; 13(21): 2547-2555. http://dx.doi.org/10.1093/hmg/ddh296 DOI: https://doi.org/10.1093/hmg/ddh296
Camprubí C, Coll MD, Villatoro S, et al. Imprinting center analysis in Prader-Willi and Angelman syndrome patients with typical and atypical phenotypes. Eur J Med Genet 2007; 50(1): 11-20. http://dx.doi.org/10.1016/j.ejmg.2006.10.001 DOI: https://doi.org/10.1016/j.ejmg.2006.10.001
Lawson-Yuen A, Wu BL, Lip V, Sahoo T, Kimonis V. Atypical cases of Angelman syndrome. Am J Med Genet A 2006; 140(21): 2361-2364. http://dx.doi.org/10.1002/ajmg.a.31481 DOI: https://doi.org/10.1002/ajmg.a.31481
Fairbrother LC, Cytrynbaum C, Boutis P, Buiting K, Weksberg R, Williams C. Mild Angelman syndrome phenotype due to a mosaic methylation imprinting defect. Am J Med Genet A 2015; 167(7): 1565-1569. http://dx.doi.org/10.1002/ajmg.a.37058 DOI: https://doi.org/10.1002/ajmg.a.37058
Zilina O, Kahre T, Talvik I, Oiglane-Shlik E, Tillmann V, Ounap K. Mosaicism for maternal uniparental disomy 15 in a boy with some clinical features of Prader-Willi syndrome. Eur J Med Genet 2014; 57(6): 279-283. http://dx.doi.org/10.1016/j.ejmg.2014.03.007 DOI: https://doi.org/10.1016/j.ejmg.2014.03.007
Wechsler D. Wechsler Adult Intelligence Scale - 3rd ed. San Antonio: The Psychological Corporation; 1997. DOI: https://doi.org/10.1037/t49755-000
Roid GH, Miller LJ. Leiter-R: Leiter International Performance Scale - Revised. Firenze: Giunti OS Edizioni Speciali; 1997. DOI: https://doi.org/10.1037/t05120-000
Griffiths R. The Abilities of Young Children. ARICD: Amersham; 1984.
Sparrow SS, Cicchetti DV, Balla DA. Vineland Adaptive Behavior Scales: 2nd Edition. Livonia: Pearson Assess¬ments; 2005. DOI: https://doi.org/10.1037/t15164-000
Kubota T, Das S, Christian SL, Baylin SB, Herman JG, Ledbetter DH. Methylation-Specific PCR Simplifies Imprinting Analysis. Nat Genet 1997; 16(1): 16-17. DOI: https://doi.org/10.1038/ng0597-16
Saitoh S, Buiting K, Rogan PK, et al. Minimal definition of the imprinting center and fixation of a chromosome 15q11-q13 epigenotype by imprinting mutations. Proc Natl Acad Sci USA 1996; 93(15): 7811-7815. http://dx.doi.org/10.1073/pnas.93.15.7811 DOI: https://doi.org/10.1073/pnas.93.15.7811
Liehr T. Cytogenetic contribution to uniparental disomy (UPD). Mol Cytogenet 2010; 3: 8. http://dx.doi.org/10.1186/1755-8166-3-8 DOI: https://doi.org/10.1186/1755-8166-3-8
Robinson WP. Mechanisms leading to uniparental disomy and their clinical consequences. BioEssays 2000; 22(5): 452-459. http://dx.doi.org/10.1002/(SICI)1521-1878(200005)22:5<452::AID-BIES7>3.0.CO;2-K DOI: https://doi.org/10.1002/(SICI)1521-1878(200005)22:5<452::AID-BIES7>3.0.CO;2-K